IL HB3533 | 2021-2022 | 102nd General Assembly
Status
Sponsorship: Partisan Bill (Democrat 2)
Status: Introduced on February 19 2021 - 25% progression, died in committee
Action: 2021-04-23 - Rule 19(a) / Re-referred to Rules Committee
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on February 19 2021 - 25% progression, died in committee
Action: 2021-04-23 - Rule 19(a) / Re-referred to Rules Committee
Pending: House Rules Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Amends the Illinois Controlled Substances Act. Provides that a prescriber shall provide information to all patients receiving a prescription for opioids on overdose prevention and the use of naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression.
Title
NALOXONE INFORMATION
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2021-04-23 | House | Rule 19(a) / Re-referred to Rules Committee |
| 2021-04-21 | House | Held on Calendar Order of Second Reading - Short Debate |
| 2021-04-21 | House | Second Reading - Short Debate |
| 2021-04-08 | House | Placed on Calendar 2nd Reading - Short Debate |
| 2021-03-26 | House | Do Pass / Short Debate Mental Health & Addiction Committee; 016-000-000 |
| 2021-03-16 | House | Assigned to Mental Health & Addiction Committee |
| 2021-03-11 | House | Added Co-Sponsor Rep. Kambium Buckner |
| 2021-02-22 | House | Referred to Rules Committee |
| 2021-02-22 | House | First Reading |
| 2021-02-19 | House | Filed with the Clerk by Rep. Deb Conroy |
Code Citations
Illinois State Sources
| Type | Source |
|---|---|
| Summary | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=3533&GAID=16&DocTypeID=HB&SessionID=110&GA=102 |
| Text | https://www.ilga.gov/legislation/102/HB/10200HB3533.htm |
